PATENT CLAIM ANALYSIS

Application Number: 16007046
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "006200"]

Abstract:
Insulin dimers and insulin analog dimers that act as partial agonists at the insulin receptor are disclosed.

Claim (Index 75):
A composition comprising one or more compounds of  claim 74  and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 94.0
- Lexical Diversity: 1.125
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14945461', '16301010', '14431040', '14504476', '15191584']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.813050747783742
- 35 USC 102 Novelty (BERT): 0.605207674533328
- Combined Prediction Score: 0.7922664404587005
- Mean Citation Score: 447.387708
- Max Citation Score: 682.5196
- Similarity Product: 442.7404968110324

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test